Abiopharma

HUTCHMED DRC (HCM) Files Form 6-K

Innate Pharma (IPHYF) Files Form 6-K

New Form EFFECT - Acurx Pharmaceuticals, Inc. Filed: 2026-01-06 AccNo: 9999999995-26-000076 Size: 1 KB

New Form EFFECT - Lifeward Ltd. Filed: 2026-01-06 AccNo: 9999999995-26-000075 Size: 1 KB

New Form EFFECT - Minerva Neurosciences, Inc. Filed: 2026-01-06 AccNo: 9999999995-26-000082 Size: 1 KB

New Form EFFECT - SONIDA SENIOR LIVING, INC. Filed: 2026-01-06 AccNo: 9999999995-26-000081 Size: 1 KB

New Form EFFECT - Moleculin Biotech, Inc. Filed: 2026-01-06 AccNo: 9999999995-26-000083 Size: 1 KB

(75% Positive) IONIS PHARMACEUTICALS, INC. (IONS) Provides Update on studies for bepirovirsen

Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference

RadNet Names Four Leaders to Expanded Executive Roles

EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement

Labeling changes approved for RISING. Active ingredient: MECLIZINE HYDROCHLORIDE. Decision date: 01/06/2026

CureVac (CVAC) was removed from the list of traded instruments on NASDAQ exchange

Mersana Therapeutics (MRSN) was removed from the list of traded instruments on NASDAQ exchange

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016